AIIMS Bhopal Partners with Dutch Institute to Advance Personalized Medicine

The collaboration aims to explore the use of genetic data in guiding treatment decisions, to enable more individualized prescription practices.

All India Institute of Medical Sciences (AIIMS) Bhopal has entered into a research-based collaboration with the Erasmus Medical Center, Netherlands, to undertake research in pharmacogenomics.

In addition, the collaboration aims to explore the use of genetic data in guiding treatment decisions, to enable more individualized prescription practices.

Under the project, researchers will assess the clinical applicability, scalability, and cost implications of such approaches in healthcare delivery.

The research initiative will leverage pharmacogenomics-based approaches, which intend to identify how patients with different genetic profiles respond to specific drugs, which may help inform dosage selection or alternative treatments.

The study will further examine how such approaches can be integrated into routine clinical settings.

A delegation from Erasmus Medical Center, led by Peter J. Van Der Spek, visited AIIMS Bhopal to formalise the partnership. During the visit, both institutions exchanged a letter of intent to strengthen academic and research cooperation.

The proposed project, with an estimated outlay of over INR 10 crore, will be spearheaded by Dr Shubham Atal from the Department of Pharmacology at AIIMS Bhopal.

Officials have indicated that the new initiative seeks to enhance ongoing research in precision medicine by strengthening a data-driven approach and offering more personalized treatment.

Last year, AIIMS Bhopal installed the state’s first Cobas Pro Advanced Integrated Clinical Biochemistry system in its Department of Biochemistry, aimed at scaling patient outcomes and improving test turnaround time.

Stay tuned for more such updates on Digital Health News